Document Actions
International medical news:
WHICH DRUG THERAPY FOR THE METABOLIC SYNDROME ?
"Once type 2 diabetes develop in people with the metabolic syndrome, patients often require 10 or more drugs for treatment," Dr. Scott Grundy points out in a recent review of drug therapy of the metabolic syndrome.
All risk factors that cluster in people with the metabolic syndrome are potential drug targets. But treating them individually raises the issues of side effects, possible drug interactions, and increased cost of therapy. So, how can we minimize “the emerging crisis in polypharmacy?”
Read Dr. Grundy’s review published in Nature Reviews/Drug Discovery
